DOUBLEPEN OA is a dual-chamber auto-injector combining Obidoxime Chloride and Atropine Sulfate, developed for rapid first aid intervention against organophosphate and nerve agent poisoning. The system is designed to provide immediate antidotal therapy during CBRN incidents, ensuring fast response in high-risk operational environments.
DOUBLEPEN OA supports early countermeasure application during the critical pre-hospital and battlefield phase, where immediate antidote delivery is vital for survival.
*Not intended for civilian use
(Specific certifications and STANAG references are available upon request, subject to official documentation.)